FDA Reports 131 Salmonella Illnesses in 38 States Linked to Moringa Powder Investigation
The Food and Drug Administration reported July 22 that 131 people in 38 states had been infected with one of the Salmonella strains under investigation in an outbreak involving moringa leaf powder and dietary supplements containing the ingredient.
The illnesses were reported in an FDA investigation that began in January 2026. The agency said reported illness-onset dates range from Aug. 22, 2025, through June 14, 2026, meaning the update covers cases identified over nearly 10 months rather than a single wave of illnesses occurring only in July.
The investigation remains active. The FDA said it has increased screening of imported moringa powder from India and continues working with industry and federal partners to protect consumers.
What the update establishes
The FDA’s latest count is 131 reported illnesses across 38 states. The cases involve one of the outbreak strains being investigated, according to the agency’s July 22 update.
The investigation focuses on moringa leaf powder and dietary supplements that contain it. Moringa is a plant-based ingredient used in supplement products, but the FDA update does not establish that every product containing moringa is contaminated.
It also does not identify one manufacturer, brand or specific product as responsible for all 131 illnesses. The available information supports an ongoing investigation involving the ingredient and related supplements, not a final finding that all products in that category caused illness.
Federal response and import screening
The FDA said it had increased screening of imported moringa powder from India. That is the specific enforcement and monitoring step identified in the update as the agency continues examining the outbreak.
The agency also said it continues working with industry and federal partners. The source does not provide a deadline for completing the investigation or describe a final determination covering every product connected to the reported illnesses.
The federal response matters because the investigation involves a dietary-supplement ingredient that can be distributed across state lines. The reported cases already span 38 states, making the development broader than a single retailer, community or state health investigation.
What consumers and retailers should watch
The cited FDA update does not announce a national recall. It also does not provide a list of every product, brand or lot associated with the investigation. Those distinctions are important: an outbreak investigation is not the same as a finding that all moringa products are unsafe.
The FDA maintains an official safety-information portal where related product alerts, recalls and consumer advisories are posted. A listing on that portal would be a separate agency action; the existence of the portal itself does not mean that a recall has been issued in this investigation.
The update also does not state how many people were hospitalized or whether any deaths occurred. Those figures cannot be inferred from the total of 131 reported illnesses.
What happens next
For now, the known next steps are continued FDA investigation, increased screening of imported moringa powder from India, and continued coordination with industry and federal partners.
The illness-onset range may change as the investigation develops, and the agency could issue additional product alerts, recalls or consumer advisories through its safety-information channels. The approved FDA update does not give a completion date, announce such an action, or establish that every illness came from one product.
Until more information is released, the verified picture is limited but significant: 131 illnesses in 38 states are part of an active Salmonella investigation involving moringa leaf powder and supplements containing it, with federal import screening now increased.
Sources
- Outbreak Investigation of Salmonella: Moringa Leaf Powder, Food and Drug Administration
- FDA Alerts, Advisories & Safety Information, Food and Drug Administration
Look for updates to this story
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.